SLC26A4 and hearing loss disorder: Consequently, the clinical finding of an EVA in the context of hearing loss does not unequivocally imply biallelic pathogenic sequence alterations in SLC26A4, providing a strong imperative for genetic testing to offer the correct diagnosis and the best possible patient care.